[ET Net News Agency, 29 July 2021] SIMCERE PHARMA (02096) rose 10.26% to HK$10.42,
breaking above the 100-D SMA of HK$9.659.
It hits an intra-day high of HK$10.42, and an intra-day low of HK$9.5. The total shares
traded was 3.56 million, with a value of HK$35.73m. The active buy/sell ratio is 62:38,
with net buying turnover of HK$8.27m. CHINA INV INFO accounts for greatest net responsive
buying turnover of HK$2.05m, with volume weighted average price of HK$10.056. MACQUARIE
CAPITAL accounts for greatest net responsive selling turnover of HK$3.35m, with volume
weighted average price of HK$10.042. The stock has risen a combined 15.78% over the past 2
consecutive trading days.
The Hang Seng Index now rose 703 points, or 2.76% to 26,177; the Hang Seng China
Enterprises Index now rose 306 points, or 3.37% to 9,377; the Hang Seng TECH Index now
rose 448 points, or 6.96% to 6,891; with an overall turnover of HK$146.89b.
The SSE Composite Index now rose 36 points, or 1.1% to 3,398, with an overall turnover
of RMB324.33b.
The SZSE Component Index now rose 356 points, or 2.53% to 14,443, with an overall
turnover of RMB227.63b.
Basic Information
-------------------------------------------
Nominal 10.420 % Chg +10.26%
High 10.420 Low 9.500
Shares Tr 3.56m Turnover 35.73m
10-D SMA 11.165 %H.V 74.575
20-D SMA 11.762 VWAP 10.024
50-D SMA 11.365 RSI14 42.416
-------------------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 62:38, with net buying
turnover of HK$8.27m, rising a combined 15.78% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SIMCERE PHARMA (02096) 10.42 +10.26
SIHUAN PHARM (00460) 2.64 +6.02
CSPC PHARMA (01093) 10.54 +4.36
SINO BIOPHARM (01177) 6.68 +2.93
3SBIO (01530) 6.70 +1.67
FOSUN PHARMA (02196) 66.10 +9.62
WUXI APPTEC (02359) 176.90 +2.31
SH PHARMA (02607) 16.74 +3.21
HANSOH PHARMA (03692) 28.50 +5.95
PHARMARON (03759) 170.80 +1.85
-------------------------------------------------
(ed)